HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q4 2022. The put-call ratio across all filers is 3.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,870 | +5.2% | 32,051 | +0.1% | 0.16% | +13.9% |
| Q2 2023 | $2,727 | -11.2% | 32,019 | -13.7% | 0.14% | 0.0% |
| Q1 2023 | $3,071 | +54.4% | 37,123 | +46.8% | 0.14% | +42.7% |
| Q4 2022 | $1,989 | -99.9% | 25,286 | -0.4% | 0.10% | +5.5% |
| Q3 2022 | $1,880,000 | -27.2% | 25,391 | -12.0% | 0.09% | +28.2% |
| Q2 2020 | $2,584,000 | +263.4% | 28,852 | +304.8% | 0.07% | +238.1% |
| Q1 2020 | $711,000 | -92.1% | 7,128 | -92.1% | 0.02% | -89.2% |
| Q4 2018 | $9,002,000 | +27.6% | 89,968 | +46.1% | 0.19% | +55.2% |
| Q3 2018 | $7,056,000 | +80.9% | 61,576 | +41.6% | 0.12% | +86.6% |
| Q2 2018 | $3,900,000 | +389900.0% | 43,489 | +621171.4% | 0.07% | – |
| Q1 2018 | $1,000 | – | 7 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | – | 7 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nitorum Capital, L.P. | 413,122 | $16,608,000 | 4.78% |
| Altalis Capital Management LLC | 88,055 | $3,540,000 | 3.97% |
| RUTABAGA CAPITAL MANAGEMENT LLC/MA | 513,619 | $20,647,000 | 3.54% |
| Black Creek Investment Management Inc. | 1,118,613 | $44,968,000 | 3.46% |
| HealthCor Management, L.P. | 1,150,000 | $46,230,000 | 2.61% |
| Van Berkom & Associates Inc. | 1,136,971 | $45,706,000 | 1.83% |
| AMERICAN CAPITAL MANAGEMENT INC | 567,896 | $22,829,000 | 1.77% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,062,539 | $82,914,000 | 1.25% |
| Legato Capital Management LLC | 1,336 | $53,707,000 | 0.97% |
| HEARTLAND ADVISORS INC | 351,314 | $14,123,000 | 0.78% |